Drainage surgery going down; cataract surgery going up

Article

The use of glaucoma drainage surgery is decreasing in Britain, which may be explained by an increase in cataract extraction, according to a report published in the January issue of Eye.

The use of glaucoma drainage surgery is decreasing in Britain, which may be explained by an increase in cataract extraction, according to a report published in the January issue of Eye.

Scott Fraser from the Sunderland Eye Infirmary, Tyne and Wear and Richard Wormald from Moorfields Eye Hospital and the London School of Hygiene and Tropical Medicine, London, UK used National Health Service (NHS) Hospital Episode Statistics (HES) to investigate a reported decrease in the rate of glaucoma surgery and whether this may be linked to increased medical therapy options.

The HES was accessed for the main glaucoma procedures between 1998 and 2004 and for cataract operations performed over the same period. Diagnostic data was extracted for glaucoma and figures for the changes in glaucoma medications were obtained from pharmaceutical data.

Over the investigated time period, trabeculectomy had reduced by 51%, laser trabeculoplasty by 60% and laser peripheral iridectomy by 30%. Cataract extractions had increased by 52% and medical treatments, such as prostaglandin use, had also increased. The number of admissions for acute glaucoma did not increase.

The results of this review, as with previous studies, demonstrate that glaucoma drainage surgery is decreasing and that cataract extraction is increasing. However, it also revealed that there was no increase in the diagnosis of angle closure glaucoma, which the researchers think may be related to the increase in cataract extractions.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.